Home
Company
Products
Strategy
- Strategic Goals
Partnering
Sustainability
- Sustainability Overview
- Reports
Media
- Events & Presentations
- News
COVID-19
Contact

Addressing_superbug_concern

May 27, 2020

Addressing_superbug_concern

Addressing the Superbug Concern: Phage Therapy Could Beat Drug Resistant Illnesses

Categories

Company News (18)
Proteon General News (1)

Recent Posts

EFSA CONFIRMS SAFETY OF BAFASAL®, A “FIRST IN CLASS”, INNOVATIVE FEED ADDITIVE
Proteon Pharmaceuticals and Skretting to co-develop new phage-based solutions for aquaculture
Proteon Pharmaceuticals – strategiczne partnerstwo handlowe z DuPont Animal Nutrition
Proteon Pharmaceuticals announces a strategic partnership in distribution with DuPont Animal Nutrition
Addressing the Superbug Concern: Phage Therapy Could Beat Drug Resistant Illnesses

Our Solutions

170131_salmonellafree_logo_456x181-e1486970860523

Contact Proteon

Your Name

Your Email

Subject *

Message *

Follow Us —

Company

Mission
Management Team
Locations
Investors
Awards

Products

Product Overview
Bafasal®
Bafador®
Product Pipeline

Partnering

Co-Development
Become a Distributor
Grants

Strategy

Strategic Goals

Sustainability

Overview
Reports

Media

Events & Presentations
Media About Us
News

logo_proteon-white

CUSTOMER SERVICE: +48 502-678-674 | proteon@proteonpharma.com

Privacy Policy | Polityka Prywatności

Copyright © 2019 Proteon Pharmaceuticals, All Rights Reserved